Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours

Patients with poor and intermediate prognosis metastatic germ-cell tumours (MGCTs) are at a significant risk of relapse after standard platinum-based chemotherapy. Novel treatment regimens are required to improve survival. Dose intense, alternating combinations of drugs with known activity in germ-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Anthoney, D A, McKean, M J, Roberts, J T, Hutcheon, A W, Graham, J, Jones, W, Paul, J, Kaye, S B
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409589/
https://www.ncbi.nlm.nih.gov/pubmed/14760371
http://dx.doi.org/10.1038/sj.bjc.6601528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409589/
https://www.ncbi.nlm.nih.gov/pubmed/14760371
http://dx.doi.org/10.1038/sj.bjc.6601528

Ejemplares similares